Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:
A randomised phase II trial from HOVON, the Dutch–Belgian Haemato-Oncology Working Group for adults
To access this article, please choose from the options below
PII: S0145-2126(04)00063-3
doi:10.1016/j.leukres.2004.03.001
© 2004 Elsevier Ltd. All rights reserved.
